NCT04795674

Brief Summary

This study will assess whether or not a novel executive working memory training intervention for Attention-Deficit/Hyperactivity Disorder can engage frontoparietal brain network treatment targets and behavioral performance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 8, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 12, 2021

Completed
8 months until next milestone

Study Start

First participant enrolled

November 1, 2021

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 19, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 19, 2023

Completed
Last Updated

August 2, 2023

Status Verified

February 1, 2023

Enrollment Period

1.4 years

First QC Date

March 8, 2021

Last Update Submit

July 31, 2023

Conditions

Keywords

Adolescents

Outcome Measures

Primary Outcomes (2)

  • Magnetic Resonance Imaging Functional Brain Scan using a Seimens 3T Skyra.

    fMRI measures of brain activation and functional connectivity - Conventional measures of 'brain activation' are estimated using GLM regression models that fit the fMRI BOLD timeseries data to a model of expected hemodynamic change as elicited by fMRI versions of the executive working memory training task trials. Functional connectivity is assessed using a form of cross-correlation analysis that quantifies how much the entire BOLD timeseries in different brain regions are similar to one another. Our a priori treatment target brain regions are the superior frontal sulcus and mid-lateral prefrontal cortex region of interest. Brain activity and functional connectivity specifically to these regions represent the primary outcome measures of the study.

    Change in fMRI measurements from baseline assessment versus 5 weeks at the conclusion of training

  • The experimental executive working memory training tasks

    Will examine changes in performance accuracy on the 4 executive working memory training tasks. These are experimental, non-published tasks being tested in this project for the first time.

    Change in scores from baseline assessment versus 5 weeks at the conclusion of training

Study Arms (2)

ADHD EWM

EXPERIMENTAL

Participants will receive EWM training sessions.

Behavioral: EWM Training

ADHD Placebo

PLACEBO COMPARATOR

Participants will receive placebo training sessions.

Behavioral: Placebo Training

Interventions

EWM TrainingBEHAVIORAL

Training tasks will target Executive Working Memory areas of the brain. Task difficulty will be adaptively increased across the 5 weeks of training based on session-to-session performance.

ADHD EWM

Computerized tasks with comparable engagement that do not tap executive working memory processes

ADHD Placebo

Eligibility Criteria

Age12 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Diagnosis of ADHD
  • English speaking
  • Right-handed
  • \>5th grade reading level
  • \>80 IQ level

You may not qualify if:

  • Braces, metal or implant devices
  • Brain abnormality, neurological disorder
  • TBI or loss of consciousness\>30 minutes
  • Diagnosis of Psychosis, Bipolar Disorder, ASD, PTSD, OCD, SUD, Tourette's Disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Living/Hartford Hospital

Hartford, Connecticut, 06106, United States

Location

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental Disorders

Study Officials

  • Michael C Stevens, PhD

    Institute of Living/Hartford Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Research Scientist

Study Record Dates

First Submitted

March 8, 2021

First Posted

March 12, 2021

Study Start

November 1, 2021

Primary Completion

March 19, 2023

Study Completion

March 19, 2023

Last Updated

August 2, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations